Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.3.2 is now displayed on the page, replacing the previous Revision: v3.3.1. This appears to be a minor metadata update with no changes to the study content or user-facing functionality.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded a PubMed auto-fill note stating that publications are automatically pulled from PubMed and may not pertain to the study. Updated the page revision to v3.3.1 (replacing v3.2.0).SummaryDifference0.0%

- Check32 days agoChange DetectedThe funding lapse notice banner warning that information may not be up to date has been removed from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study page content remains unchanged, with only minor UI layout or timestamp differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedLocation region label updated from Rhone-Alpes to Auvergne-Rhône-Alpes; Pierre-Bénite, Rhone-Alpes, France, 69495 is replaced with Pierre-Bénite, Auvergne-Rhône-Alpes, France, 69495.SummaryDifference0.1%

- Check76 days agoChange DetectedUpdated the page to show revision v3.2.0 and removed v3.0.2. This indicates a software/version update indicator on the page.SummaryDifference0.0%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.